Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces robust neutralizing salivary IgA
M. Stolovich-Rain, S. Kumari, A. Friedman, S. Kirillov, Y. Socol, M. Billan, R. Ranjan Pal, P. Golding, E. Oiknine-Djian, S. Sirhan, M. Bejerano Sagie, E. Cohen-Kfir, M. Elgrably-Weiss, B. Zhou, M. Ravins, , A. Rouvinski
This study shows that the BNT162b2 mRNA vaccine induces temporary salivary IgA with strong neutralizing activity against SARS-CoV-2.
Frontiers in Immunology · Jan 30, 2023Peer-reviewedMicrobiology